1-7 of 7
Ming Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Studies of OBI-999: A Novel Globo H–Targeting Antibody–Drug Conjugate

Ming-Chen Yang, Chi-Sheng Shia, Wan-Fen Li, Chun-Chung Wang, I-Ju Chen, Teng-Yi Huang, Yu-Jung Chen, Hui-Wen Chang, Chi-Huan Lu, Yueh-Chin Wu, Nan-Hsuan Wang, Jiann-Shiun Lai, Cheng-Der Yu, Ming-Tain Lai
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (6): 1121–1132.
https://doi.org/10.1158/1535-7163.MCT-20-0763
Published: 01 June 2021
View article titled, Preclinical Studies of OBI-999: A Novel Globo H–Targeting Antibody–Drug Conjugate
Open the PDF for Preclinical Studies of OBI-999: A Novel Globo H–Targeting Antibody–Drug Conjugate in another window
Includes: Supplementary data
Journal Articles

LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P

Zonghao You, Chunhui Liu, Can Wang, Zhixin Ling, Yiduo Wang, Yali Wang, Minghao Zhang, Shuqiu Chen, Bin Xu, Han Guan, Ming Chen
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (12): 2469–2479.
https://doi.org/10.1158/1535-7163.MCT-19-0095
Published: 02 December 2019
View article titled, LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P
Open the PDF for LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P in another window
Includes: Supplementary data
Journal Articles

Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors

Qiang Zhang, Jianghao Xu, Yi Qian, Liang Chen, Qingya Li, Kangjing Xu, Ming Chen, Luning Sun, Zhongyuan He, Li Yang, Diancai Zhang, Linjun Wang, Xiaofeng Sun, Yongqing Wang, Hao Xu, Zekuan Xu
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2018) 17 (12): 2780–2787.
https://doi.org/10.1158/1535-7163.MCT-18-0498
Published: 03 December 2018
View article titled, Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors
Open the PDF for Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors in another window
Includes: Supplementary data
Journal Articles

GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression

Sandra Baumgart, Nai-Ming Chen, Jin-San Zhang, Daniel D. Billadeau, Irina N. Gaisina, Alan P. Kozikowski, Shiv K. Singh, Daniel Fink, Philipp Ströbel, Caroline Klindt, Lizhi Zhang, William R. Bamlet, Alexander Koenig, Elisabeth Hessmann, Thomas M. Gress, Volker Ellenrieder, Albrecht Neesse
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (3): 491–502.
https://doi.org/10.1158/1535-7163.MCT-15-0309
Published: 06 March 2016
View article titled, GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Open the PDF for GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression in another window
Includes: Supplementary data
Journal Articles

Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia

Santi Suryani, Lauryn S. Bracken, Richard C. Harvey, Keith C.S. Sia, Hernan Carol, I-Ming Chen, Kathryn Evans, Philipp A. Dietrich, Kathryn G. Roberts, Raushan T. Kurmasheva, Catherine A. Billups, Charles G. Mullighan, Cheryl L. Willman, Mignon L. Loh, Stephen P. Hunger, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (2): 364–374.
https://doi.org/10.1158/1535-7163.MCT-14-0647
Published: 09 February 2015
View article titled, Evaluation of the <em>In Vitro</em> and <em>In Vivo</em> Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia
Open the PDF for Evaluation of the <em>In Vitro</em> and <em>In Vivo</em> Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia in another window
Includes: Supplementary data
Journal Articles

Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy

Kuo-Hsiang Chuang, Hsin-Ell Wang, Fang-Ming Chen, Shey-Cherng Tzou, Chiu-Min Cheng, Ya-Chen Chang, Wei-Lung Tseng, Jentaie Shiea, Shiu-Ru Lin, Jaw-Yuan Wang, Bing-Mae Chen, Steve R. Roffler, Tian-Lu Cheng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1903–1912.
https://doi.org/10.1158/1535-7163.MCT-09-0899
Published: 09 June 2010
View article titled, Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy
Open the PDF for Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy in another window
Includes: Multimedia, Supplementary data
Journal Articles

Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer

Dorit Nahari, Ronit Satchi-Fainaro, Ming Chen, Ian Mitchell, Laurie B. Task, Zijuan Liu, Jason Kihneman, Allison B. Carroll, Lance S. Terada, Fiemu E. Nwariaku
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (4): 1329–1337.
https://doi.org/10.1158/1535-7163.MCT-06-0554
Published: 12 April 2007
View article titled, Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer
Open the PDF for Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer in another window